10.1038/s41467-020-15983-6 88 KnerrP
Food and Drug Administration recently announced plans to crack down on the active pharmaceutical ingredients used in glucagonlike peptide 1 (GLP-1) drugs produced at compounding pharmacies, which make customized medications when FDA-approved drugs are unavailable
If that's the case for you, watchful waiting could be the best option
This precision approach eliminates guesswork and ensures your medications match your biology, not supplement trends
Patients experiencing recurrent or persistent injection site reactions should discuss these concerns with their prescribing clinician, who may consider alternative formulations, dose adjustments, or switching to a different medication if symptoms significantly impact quality of life or treatment adherence
Start as low as 5 billion and increasing to as many as 25 billion CFUs daily (best done under a doctors supervision if you have GI symptoms)